Transendothelial Transport and Its Role in Therapeutics

Present review paper highlights role of BBB in endothelial transport of various substances into the brain. More specifically, permeability functions of BBB in transendothelial transport of various substances such as metabolic fuels, ethanol, amino acids, proteins, peptides, lipids, vitamins, neurotransmitters, monocarbxylic acids, gases, water, and minerals in the peripheral circulation and into the brain have been widely explained. In addition, roles of various receptors, ATP powered pumps, channels, and transporters in transport of vital molecules in maintenance of homeostasis and normal body functions have been described in detail. Major role of integral membrane proteins, carriers, or transporters in drug transport is highlighted. Both diffusion and carrier mediated transport mechanisms which facilitate molecular trafficking through transcellular route to maintain influx and outflux of important nutrients and metabolic substances are elucidated. Present review paper aims to emphasize role of important transport systems with their recent advancements in CNS protection mainly for providing a rapid clinical aid to patients. This review also suggests requirement of new well-designed therapeutic strategies mainly potential techniques, appropriate drug formulations, and new transport systems for quick, easy, and safe delivery of drugs across blood brain barrier to save the life of tumor and virus infected patients.

• Publication year

  2014

• Venue

  International Scholarly Research Notices

• Publication date

  2014-08-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2014/309404PMID 27355037PMCID 4897564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood-brain barrier in health and disease.

  2015cited by this paper
• Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.

  2014cited by this paper
• GABAergic Neurogliaform Cells Represent Local Sources of Insulin in the Cerebral Cortex

  2014cited by this paper
• Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?

  2014cited by this paper
• Motor dysfunction in cerebellar Purkinje cell-specific vesicular GABA transporter knockout mice

  2014cited by this paper
• Human aquaporins: regulators of transcellular water flow.

  2014cited by this paper
• Molecular and functional characterization of multiple aquaporin water channel proteins from the western tarnished plant bug, Lygus hesperus.

  2014cited by this paper
• Insights into structural mechanisms of gating induced regulation of aquaporins.

  2014cited by this paper
• The proinflammatory peptide substance P promotes blood–brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions

  2014cited by this paper
• Iron uptake and transfer from ceruloplasmin to transferrin.

  2014cited by this paper
• Receptors of peptides as therapeutic targets in epilepsy research.

  2014cited by this paper
• Stress-induced stimulation of choline transport in cultured choroid plexus epithelium exposed to low concentrations of cadmium.

  2014cited by this paper
• Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism

  2014cited by this paper
• Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier

  2014cited by this paper
• Aquaporins: Highly Regulated Channels Controlling Plant Water Relations1

  2014cited by this paper
• Excitatory amino acid transporters: roles in glutamatergic neurotransmission.

  2014cited by this paper
• Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayers

  2014cited by this paper
• A Computational Model of Oxygen Transport in the Cerebrocapillary Levels for Normal and Pathologic Brain Function

  2013cited by this paper
• Nanofiber-based delivery of therapeutic peptides to the brain.

  2013cited by this paper
• Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood–brain barrier

  2013cited by this paper
• Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.

  2013cited by this paper
• Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease.

  2013cited by this paper
• Receptor-Mediated Endocytosis and Brain Delivery of Therapeutic Biologics

  2013cited by this paper
• End-tidal carbon dioxide as a measure of stress response to clustered nursing interventions in neurologic patients.

  2013cited by this paper
• Monocarboxylic acid transport.

  2013influential reference
• Extracellular ATP-prinoceptor signaling and AMP-activated protein kinase regulate astrocytic glucose transporter 3 in an in vitro ischemia.

  2013cited by this paper
• Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor

  2013cited by this paper
• [Chemotherapy in conjunction with blood brain barrier disruption in the treatment of primary central nervous system lymphoma].

  2013cited by this paper
• Peptide and protein delivery using new drug delivery systems.

  2013cited by this paper
• Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.

  2013cited by this paper
• [The role of glucose transporters in human metabolic regulation].

  2013cited by this paper
• In-vivo evaluation of the permeability of the blood–brain barrier to arsenicals, molybdate, and methylmercury by use of online microdialysis–packed minicolumn–inductively coupled plasma mass spectrometry

  2013cited by this paper
• The metal transporter SMF‐3/DMT‐1 mediates aluminum‐induced dopamine neuron degeneration

  2013cited by this paper
• Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies.

  2013cited by this paper
• Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting.

  2013cited by this paper
• Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography

  2013cited by this paper
• Increased brain uptake and oxidation of acetate in heavy drinkers.

  2013cited by this paper
• Update on cerebral uptake of blood ammonia

  2013influential reference
• Phox2b-Expressing Retrotrapezoid Neurons Are Intrinsically Responsive to H+ and CO2

  2013cited by this paper
• Melatonin modulates baroreflex control via area postrema

  2013cited by this paper
• Development and automation of a novel NET-PET tracer: [11C]Me@APPI.

  2013cited by this paper
• Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.

  2013cited by this paper
• Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of

  2013cited by this paper
• Alcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol‐preferring (P) rats

  2013cited by this paper
• In vitro and in vivo study of dolichyl phosphate on the efflux activity of P‐glycoprotein at the blood–brain barrier

  2013cited by this paper
• Neuroprotective effect of melatonin in experimentally induced hypobaric hypoxia.

  2013cited by this paper
• Does menaquinone participate in brain astrocyte electron transport?

  2013cited by this paper
• Antihypertensives, angiotensin, glucose and Alzheimer’s disease

  2013cited by this paper
• Pathophysiology of acute brain dysfunction: what's the cause of all this confusion?

  2012cited by this paper
• Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake.

  2012cited by this paper
• Peptide therapeutics for CNS indications.

  2012cited by this paper
• La barrière hémato-encéphalique lors de l’ischémie cérébrale : une cible thérapeutique

  2012cited by this paper
• Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.

  2012cited by this paper
• Regulation of Mct1 by cAMP-dependent internalization in rat brain endothelial cells.

  2012influential reference
• The blood-brain barrier choline transporter.

  2012cited by this paper
• H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.

  2012cited by this paper
• Neurological disorders and therapeutics targeted to surmount the blood–brain barrier

  2012cited by this paper
• Strategies to minimize CNS toxicity: in vitro high-throughput assays and computational modeling

  2012cited by this paper
• The apical ectoplasmic specialization-blood-testis barrier functional axis is a novel target for male contraception.

  2012cited by this paper
• Transport of Biogenic Amine Neurotransmitters at the Mouse Blood–Retina and Blood–Brain Barriers by Uptake1 and Uptake2

  2012cited by this paper
• Alcohol-induced oxidative/nitrosative stress alters brain mitochondrial membrane properties

  2012cited by this paper
• Significance of Short Chain Fatty Acid Transport by Members of the Monocarboxylate Transporter Family (MCT)

  2012cited by this paper
• Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology.

  2012cited by this paper
• Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis.

  2012cited by this paper
• The blood–brain barrier in health and disease

  2012cited by this paper
• Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice.

  2012cited by this paper
• [Dysfunction of the blood-brain barrier during ischaemia: a therapeutic concern].

  2012cited by this paper
• Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis.

  2011cited by this paper
• Epinephrine: A Short- and Long-Term Regulator of Stress and Development of Illness

  2011cited by this paper
• SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation

  2011cited by this paper
• Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.

  2011cited by this paper
• Altered tryptophan and alanine transport in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD): an in vitro study

  2011cited by this paper
• HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.

  2011cited by this paper
• DMT1 polymorphism and risk of Parkinson's disease.

  2011cited by this paper
• Exploiting nutrient transporters at the blood-brain barrier to improve brain distribution of small molecules.

  2010cited by this paper
• Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporter.

  2010cited by this paper
• Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier

  2010cited by this paper
• Selective Transport of Monoamine Neurotransmitters by Human Plasma Membrane Monoamine Transporter and Organic Cation Transporter 3

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons

  2009cited by this paper
• Molecular dissection of reactive astrogliosis and glial scar formation.

  2009cited by this paper
• Neuro-transmitters in the central nervous system & their implication in learning and memory processes.

  2009influential reference
• Gastrointestinal hormone actions in the central regulation of energy metabolism: potential sensory roles for the circumventricular organs

  2009cited by this paper
• Astrocytes and Ischemic Injury

  2009cited by this paper
• Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy.

  2009cited by this paper
• Drug delivery to brain tumors

  2008cited by this paper
• Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders.

  2008cited by this paper
• A cholecystokinin‐1 receptor agonist (CCK‐8) mediates increased permeability of brain barriers to leptin

  2008cited by this paper
• Manganese transport in eukaryotes: the role of DMT1.

  2008cited by this paper
• The mystery and magic of glia: a perspective on their roles in health and disease.

  2008cited by this paper
• Systemic and myocardial oxygen transport responses to brain death in pigs.

  2007influential reference
• REVIEW: Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E

  2007cited by this paper
• Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications

  2007cited by this paper
• Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues.

  2007cited by this paper
• Molecular genetic studies of DMT1 on 12q in French‐Canadian restless legs syndrome patients and families

  2007cited by this paper
• Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities

  2007cited by this paper
• Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration

  2006cited by this paper
• Astrocyte dysfunction in neurological disorders: a molecular perspective

  2006cited by this paper
• The transport of manganese across the blood-brain barrier.

  2006cited by this paper
• A compartmental model for oxygen transport in brain microcirculation

  2006cited by this paper

• Crossing the Blood–Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies

  2025cites this paper
• Engineered RVG29-Conjugated Chitosan for Enhanced Brain Delivery of Kisspeptin Agonists and Antagonists in Reproductive Health

  2025cites this paper
• Incubator-Free Organoid Culture in a Sealed Recirculatory System

  2025cites this paper
• Novel Therapeutic Strategies for Neuropsychiatric Treatments: Targeted and Controlled Drug Delivery Approaches

  2025cites this paper
• Unravelling the genetic and molecular basis of low-frequency rTMS induced changes in functional connectivity density in schizophrenia patients with auditory verbal hallucinations

  2025cites this paper
• Advance Nanotechnology-Based Drug Delivery Systems for Alzheimer's Disease: Advancements and Future Perspectives.

  2025cites this paper
• Intranasal delivery of liposome encapsulated flavonoids ameliorates l-DOPA induced dyskinesia in hemiparkinsonian mice.

  2024cites this paper
• CPD: The impact of harmful substances on eye health

  2024cites this paper
• Cytotoxic Activity of Bioactve Compounds from Hydroid Aglophenia cupressina Lamoureoux against Hela Tumor Cells

  2024cites this paper
• Microglia and Systemic Immunity.

  2024cites this paper
• Fenugreek derived diosgenin as an emerging source for diabetic therapy

  2024cites this paper
• Structure of the Blood Brain Barrier and its role in the transporters for the movement of substrates across the barriers.

  2023cites this paper
• Recent update on pharmacokinetics and drug metabolism in CNS-based drug discovery.

  2023cites this paper
• Microalgae biofilm system as an efficient tool for wastewater remediation and potential bioresources for pharmaceutical product production: an overview

  2023cites this paper
• Co-Delivery of Therapeutics and Bioactive Gas Using a Novel Liposomal Platform for Enhanced Treatment of Acute Arterial Injury

  2023cites this paper
• Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease

  2022cites this paper
• Nanomedicines encountering HIV dementia: A guiding star for neurotherapeutics

  2022cites this paper
• Advances in Hydrogel-Based Microfluidic Blood–Brain-Barrier Models in Oncology Research

  2022cites this paper
• Nanotechnology-based approaches in diagnosis and treatment of epilepsy

  2022cites this paper
• Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases.

  2022cites this paper
• Structure of the Blood Brain Barrier and the Role of Transporters in the movement of substrates across the barriers

  2022cites this paper
• Blood–Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders

  2022cites this paper
• Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications

  2021cites this paper
• Diethylene glycol and its metabolites induce cell death in SH-SY5Y neuronal cells in vitro.

  2021cites this paper
• Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia

  2021cites this paper
• Liver X Receptor as a Possible Drug Target for Blood-Brain Barrier Integrity

  2021cites this paper
• Role of Intermediate Filaments in Blood–Brain Barrier in Health and Disease

  2021cites this paper
• The Role of Nutrition in Space Exploration: Implications for Sensorimotor, Cognition, Behavior and the Cerebral Changes due to the Exposure to Radiation, Altered Gravity, and Isolation/Confinement Hazards of Spaceflight.

  2021cites this paper
• Bioengineered microfluidic blood-brain barrier models in oncology research

  2021cites this paper
• Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

  2020cites this paper
• Entropy and potential energy as a key role of halalopathy in disease prevention and cure

  2020cites this paper
• Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation

  2020cites this paper
• Magnetic Resonance Methods for Focused Ultrasound-Induced Blood-Brain Barrier Opening

  2020cites this paper
• Blood Brain Barrier Crossing for Therapeutic and Diagnostic Agents

  2019cites this paper
• Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies.

  2019cites this paper
• Levels of 25-hydroxyvitamin D3, biochemical parameters and symptoms of depression and anxiety in healthy individuals

  2019cites this paper
• Microphysiological systems for recapitulating physiology and function of blood-brain barrier.

  2019cites this paper
• Leaky brain in neurological and psychiatric disorders: Drivers and consequences

  2018cites this paper
• Neurochemistry of Neurochemicals: Messengers of Brain Functions

  2017cites this paper
• Is the Cannabinoid CB2 Receptor a Major Regulator of the Neuroinflammatory Axis of the Neurovascular Unit in Humans?

  2017cites this paper
• Rola składników diety w syntezie wybranych neurotransmiterów

  2016cites this paper
• Azadirachta indica (Neem) Gum Coated Gold Nanoparticles as Nano-go-karts to

  2016cites this paper
• Role(s) of the mitochondrial type-1 cannabinoid receptor in the brain

  2015cites this paper
• Peptide and protein delivery using new drug delivery systems.

  2013cites this paper